Depakote®

Depakote® was initially approved by the Food & Drug Administration (FDA) in 1983 for the treatment of epilepsy. It was later indicated as a treatment for bipolar disorder and the prevention of migraine headaches. Depakote® use before or during pregnancy has been linked to:

  • Heart defects
  • Pulmonary hypertension
  • Spina bifida
  • Cleft palate
  • Facial dysmorphism
  • Limb reduction defect
  • Other skeletal abnormalities.

Protect your rights. Get compensated for your injuries.

If you or a loved one have given birth to a baby with birth defects after taking Depakote®, you may be entitled to compensation. Complete the Quick Intake form at the top of this page or call our legal intake center at 1 (800) 438-6453 to receive your FREE case evaluation.